Significance
The ease of diversification of 2-Substituted-Alkynyl-1-Sulfonyl Fluorides through numerous reaction pathways further validates Diversity Oriented Clicking as an effective and robust method for lead discovery; one of the fundamental goals of click chemistry. The application of this approach is showcased by the discovery of a novel class of covalent inhibitors of the human neutrophil elastase, an attractive therapeutic target due to its implication in numerous chronic diseases. These molecules provide a prime example of the Sleeping Beauty effect in action, bio-compatible SuFEx reactions mediated by environmental factors unique to the “live” protein system, securing sulfur-fluoride-containing ligands as promising covalent therapeutics.
Keywords: Diversity Oriented Clicking, SuFEx, Michael addition, human neutrophil elastase, covalent inhibitor
Abstract
Diversity Oriented Clicking (DOC) is a discovery method geared toward the rapid synthesis of functional libraries. It combines the best attributes of both classical and modern click chemistries. DOC strategies center upon the chemical diversification of core “SuFExable” hubs—exemplified by 2-Substituted-Alkynyl-1-Sulfonyl Fluorides (SASFs)—enabling the modular assembly of compounds through multiple reaction pathways. We report here a range of stereoselective Michael-type addition pathways from SASF hubs including reactions with secondary amines, carboxylates, 1H-1,2,3-triazole, and halides. These high yielding conjugate addition pathways deliver unprecedented β-substituted alkenyl sulfonyl fluorides as single isomers with minimal purification, greatly enriching the repertoire of DOC and holding true to the fundamentals of modular click chemistry. Further, we demonstrate the potential for biological function – a key objective of click chemistry – of this family of SASF-derived molecules as covalent inhibitors of human neutrophil elastase.
Diversity Oriented Clicking (DOC) (1) is a unified click chemistry approach for the modular synthesis of functional molecules and achieving “diversity with ease” (2). DOC combines the essence of classical click philosophy and reactivity with modern sulfur(VI) fluoride exchange (SuFEx) technology, exemplified through the multiple click-cycloaddition pathways of 2-Substituted-Alkynyl-1-Sulfonyl Fluoride (SASF) connective hubs (3–5).
The family of existing “SuFExable” functionality is grouped into two distinct categories: 1) inorganic high oxidation state sulfur compounds that are heavily functionalized with exchangeable sulfur-fluoride bonds (6, 7), e.g., sulfuryl fluoride (SO2F2) (8) and thionyl tetrafluoride (SOF4) (9), and 2) high oxidation state sulfur-fluoride containing head groups that are combined with organic functionality, e.g., alkyl/aryl sulfonyl fluorides, aromatic fluorosulfates, ethenesulfonyl fluoride (ESF) (10, 11), 1-bromoethenesulfonyl fluoride (BESF) (12–14), 2-substituted-alkynyl-1-sulfonyl fluorides (SASFs) (1), sulfamoyl fluorides (15–18), sulfonimidoyl fluorides (19) and sulfondiimidoyl fluorides (20) (selected examples shown in Fig. 1A). Each hub offers a multitude of pathways for synthesizing structurally diverse compounds with interesting functional properties, demonstrated by our recent report on the DOC of SASF hubs to deliver a library of distinct SuFExable pharmacophores (Fig. 1B) (1). Although β-functionalization of 2-substituted-alkenyl-1-sulfonyl fluorides (21) and 2-substituted-alkynyl-1-triflones (22) is known, the Michael addition chemistry of SASFs has not been previously reported.
Fig. 1.
(A) Examples of SuFEx-compatible hubs. (B) DOC of SASFs. (C) This work: DOC of SASF hubs through Michael addition pathways.
SuFEx click chemistry affords the potential to modify proteins covalently; a technique with broad application in chemical biology (23), not least, bioconjugation (24, 25), target identification (26–28), inverse drug discovery (29), and activity-based protein profiling (30, 31). Examples of the selective in vitro or in vivo covalent capture of proteins by SuFEx-based probes are steadily growing (3). These events are made possible by environments that facilitate extraction of fluoride, such as proximal arginine side chains (27), and felicitous electrostatic and electric field effects that are distinct for all-natural proteins (32–35). In 2019 Sharpless, Wolan, and coworkers reported a new class of covalent inhibitors of human neutrophil elastase (hNE), identified through an agnostic screen of a library of sulfur-fluoride containing ligands (36). A member of the serine protease superfamily, hNE is aberrantly active in cystic fibrosis, chronic obstructive pulmonary disease, and inflammatory bowel diseases (37–44), and hence, an attractive target for drug discovery.
Through exploring the Michael addition pathways from SASF hubs with a range of nucleophiles, we report herein the synthesis of a diverse library of unprecedented β-substituted ethenesulfonyl derivatives (Fig. 1C). The nature of the β-substituent influences the electrophilicity of the sulfonyl fluoride head group through a “push- and pull-like” distribution of electron density from the electron donating amine moiety on one end of the C=C double bond, and electron withdrawing sulfonyl fluoride group on the other end. The balance of these opposing forces fine tunes the reactivity of the β-substituted ESF derivatives toward incoming nucleophiles (Fig. 6). This ability to refine the electrophilicity of a reactive covalent group is highly desirable for drug discovery applications, and in-principle, should facilitate the design of covalent agents that are capable of selectively modifying target proteins through a “Sleeping Beauty” event, a perfect matchmaking with complete selectivity observed for living, but not denatured, biotargets (45). Through screening our library of novel ligands against hNE, we demonstrate the matched pair discovery of a new class of irreversible covalent inhibitors of hNE.
Fig. 6.
SuFEx reactivity of β-disubstituted ESF. (A) Secondary amine adduct 4-6. (B) 1,2,3-Triazole adduct 4-16.
Results and Discussion
To assess the reactivity of SASFs toward Michael-type addition chemistry, morpholine (1.0 eq.) was added in one portion to a solution of Ph-SASF (1) in CH3CN at room temperature. The stereoselective reaction reached complete conversion within minutes, generating exclusively the E-isomer addition product in >99% yield (Fig. 2A, 2-1). An NOE correlation between HA and HB (Fig. 2B) was used to determine the stereochemical configuration of the product (E)-2-1 and this assignment was corroborated by single-crystal X-ray crystallography. We attribute the observed stereoselectivity of this reaction to a protonation event (Fig. 2B). After the initial attack at the triple bond, the available proton source is from the same amine that is attached to the double bond; therefore, intramolecular proton transfer occurs at the same side as the amine to generate the E-isomer exclusively. The enamine nature of the product results in a single addition, suggesting a stabilized “push-pull” state is achieved in the β-substituted ESF product.
Fig. 2.
Michael addition of amines to Ph-SASF (1): (A) Substrate scope. (B) Proposed mechanism and representative NOESY spectrum for (E)-2-1. General reaction conditions: The amine (1.0 eq.) was added to a solution of SASF (1.0 eq.) in CH3CN, and the reaction was stirred at room temperature for 10 min or until complete conversion. Reactions were conducted on a 100 µmol scale unless stated otherwise in the SI Appendix. Isolated yields are reported. a. A pair of rotamers were observed. b. 0.5 eq. isonipecotic acid was used, and 1:1 CH3CN/H2O was used as the solvent.
We next explored the scope of the Michael-type click-addition chemistry of 1 with a collection of amines. In most cases, the reactions occurred rapidly and in high yield, selectively delivering the E-isomer of β-substituted ESFs as single products (Fig. 2A, 2-2 to 2-22).1 The reaction is tolerant of a wide range of functionality, including hydroxyl 2-8, amide 2-9, nitrile 2-16, and carbonyl 2-18 groups. However, the presence of a carboxylic acid tended to slow the rate of conjugate addition, presumably due to the poor solubility of the corresponding salt in acetonitrile. When a 1:1 mixture of H2O/CH3CN was used as the solvent, the reaction of isonipecotic acid and 1 proceeded smoothly to afford the dual-addition product 2-22 in 95% yield, in which case both the amine and carboxylate groups had each reacted with an equivalent of the SASF. The reaction of piperazines proceeded smoothly (2-11 to 2-13) and even the sterically encumbered amine 1,3,3-trimethyl-6-azabicyclo[3.2.1]octane delivered product 2-14 in high yield (94%).
The SASFs were also found to be stable to thiols. For instance, reacting the 4-trifluoromethylphenyl SASF 3-1 with an equimolar amount of 1-hexanethiol in CH3CN at ambient temperature for 12 h resulted in more than 80% recovery of the SASF species, with no Michael-type adduct or other products observed.
We next explored the Michael-type reactivity of substituted SASFs with a selection of nucleophiles (Fig. 3A and C, 4-1 to 4-29). The addition of one equivalent of N,N-dipropargylamine to a variety of SASFs occurred readily to produce the corresponding ESF analogs in excellent yield (4-1 to 4-9). SASFs with alkyl substituents at the triple bond were less reactive compared with their aryl counterparts, requiring longer reaction times to achieve complete conversion (4-7 ∼30 min). The Michael addition of 1H-1,2,3-triazole to the SASFs gave exclusively the Z-products 4-15 to 4-23 in good overall yield. The Z-stereochemistry was determined by a combination of X-ray crystallography and NMR experiments. The crystal structure of 4-17 shows the triazole ring cis to the sulfonyl fluoride group, and out of plane with the π-system, whereas the NOESY spectrum of 4-16 reveals a strong NOE correlation between the alkenyl proton HA and the 4-trifluoromethylbenzene ring (HB), but not between HA and the triazole ring protons (Fig. 3B). We posit that the Z-selectivity can be explained by a proton transfer process. After initial nucleophilic attack by the 1,2,3-triazole toward the triple bond, intramolecular proton transfer is not available, while the triazole itself is acidic enough to serve as the proton source for intermolecular protonation of the more stable anion intermediator, yielding the Z-isomer as the sole product and minimizing steric clash between the phenyl and SO2F group (Fig. 3B).
Fig. 3.
Michael addition of amines and 1,2,3-triazoles to SASFs. (A) Substrate scope for aryl-SASF (3). (B) Proposed mechanism and representative NOESY spectrum for (Z)-4-16. (C) Substrate scope for triisopropylsilyl-SASF (5). General reaction conditions: The amine (1.0 eq.) was added to a solution of SASF (1.0 eq.) in CH3CN, and the reaction was stirred at room temperature for 10 min or until full conversion. Scale of reactions outlined in the General Procedures and SI Appendix. Isolated yields are reported. a. 1.5 eq. amine was used; b. yield in parenthesis was obtained when 2.0 eq. amine was used.
The addition of secondary amines to the sterically hindered triisopropylsilyl (TIPS) SASF 5 was markedly slower than with other SASFs, resulting in synchronous protodesilylation to give the E-products 4-24 to 4-29 in good to moderate yield (Fig. 3C). This new synthesis compliments Hyatt and Krutak’s MnO2 mediated dehydrogenation of β-fluorosulfonylethylamines (46) and the reaction of the 1-bromo-2-triazolethane-1-sulfonyl fluoride connective hub with amines reported by Qin et al. (47). The assigned E-stereochemistry is consistent with the previously reported syntheses (46, 47) and supported by trans-coupling constants JHA-HB ranging from 12.3 to 12.7 Hz. Replacing the -SO2F group of 5 with the corresponding-SO2CF3 also led to desilylated products, ruling out the involvement of fluoride ions in the desilylation process. When N,N-dipropargylamine was used as the donor, >90% of unreacted starting material was recovered after 1 h. When stirred overnight at room temperature, no reaction occurred between TIPS-SASF and 3-isopropylaniline. In some instances, increasing the amount of the secondary amine to 2 equivalents improved the efficiency of the reaction (4-29).
Halides were also found to be viable nucleophiles for conjugate addition to SASFs (Fig. 4A). The reaction with triethylamine trihydrofluoride (Et3N•3HF) delivered the β-fluorinated ESF products 6-1 to 6-8 in high yield with Z-selectivity as suggested by the large JF-H value (29.2 Hz in the instance of (Z)-6-4) (48) and a significant NOE correlation between HA and HB (Fig. 4B). Similarly, triethylamine hydrochloride delivered the corresponding β-chlorinated ESF products in mostly excellent yields (6-9 to 6-17), although with comparatively longer reaction times (49). The β-iodinated ESF 6-18 was available using equimolar lithium iodide and acetic acid.
Fig. 4.
Addition of halides to SASFs. (A) Substrate scope. (B) Proposed mechanism and representative NOESY spectrum for (Z)-6-4. General reaction conditions: halide source was added to a solution of SASF (1.0 eq.) in CH3CN and the reaction was stirred at room temperature until complete conversion. Reactions were conducted on a 200 µmol scale unless stated otherwise in the SI Appendix. Isolated yields are reported. a. Et3N•3HF (0.5 eq.) was used. b. Et3N•HCl (1.1 eq.) was used in CH2Cl2 at 0 °C followed by stirring at room temperature for 16 h; c. LiI (1.0 eq.) and HOAc (1.0 eq.) were used.
The addition of carboxylic acids to SASFs was next explored in the presence of 1.1 equivalents of triethylamine in CH3CN, delivering the β-ester-substituted ESF products 7-1 to 7-17 in excellent yield with a short reaction time of 30 min (Fig. 5A). As with 1H-1,2,3-triazole, and halides, the addition of carboxylic acids proceeds with the Z-selectivity as determined by NOESY experiments (Fig. 5B) and corroborated by single-crystal X-ray crystallography (7-11). For the addition of halides and carboxylates to the SASFs, there is no opportunity for an intramolecular proton transfer, therefore, an intermolecular proton transfer occurs from the protonated triethylamine, favoring the Z-isomer (Fig. 4B and 5B).
Fig. 5.
Addition of carboxylic acids to SASFs. (A) Substrate scope. (B) Proposed mechanism and representative NOESY spectrum for (Z)-7-9. General reaction conditions: Et3N (1.1 eq.) was added to a solution of SASF (1.0 eq.) and carboxylic acid (1.0 eq.) in CH3CN, and the reaction was stirred at room temperature for 30 min. Reactions were conducted on a 100 µmol scale unless stated otherwise in the SI Appendix. Isolated yields are reported.
We next studied the relative reactivity of the novel β-substituted ESFs. As expected, the electron-donating effects of the secondary amine substituents strongly deactivated both the -SO2F group and double bond. Even when heated at 80 °C for several hours, secondary amines did not undergo conjugate addition to β-amino-substituted ESFs. When PhOTBS (8) 1.1 eq. was reacted with the derivative 4-6 under standard SuFEx conditions [DBU (20 mol%), CH3CN], the exchange reaction occurred exclusively at the fluorosulfate to give the product 9 in quantitative yield (Fig. 6A). In a separate experiment with the 1,2,3-triazole-substituted ESF 4-16 and PhOTBS (8), the -SO2F group showed higher SuFEx reactivity than that of β-amino-substituted ESFs. Here, the anticipated sulfonate product 10 was obtained in good yield (Fig. 6B).
One of the key objectives of click chemistry is the discovery of functional molecules. Therefore, with a collection of over 80 novel β-substituted ESF hubs in hand, we elected to screen the products for biological activity against hNE (36). First, the stability of the compounds was evaluated in an aqueous buffer solution at different pH values. The amine-substituted ESFs were unstable under acidic conditions, while β-fluorinated ESFs and 1,2,3-triazole-substituted ESFs decomposed within 1 h at pH 10. However, at pH 7.4, the compounds were stable over 6 h.
A kinetic assay using hNE was next employed to evaluate the inhibitory effects of the compounds. Pure hNE was incubated with compounds at different concentrations in phosphate-buffered saline (PBS, pH = 7.4) supplemented with 0.05% (vol/vol) Nonidet P-40 for 10 min before the addition of substrate. The proteolytic activity of hNE was measured at 25 °C for 30 min at 30-s intervals, and the IC50 values were obtained by fitting the data to dose-dependent inhibition. The fine tuning of SuFEx reactivity through the β-substituent effects is clearly demonstrated in the series of ligands: the β-amino-substituted and β-fluorinated ESFs showed no meaningful inhibition of hNE at the concentrations tested (>200 mM), while several 1,2,3-triazole-substituted ESFs and β-ester-substituted ESFs demonstrated good inhibition of this enzyme with IC50 values in the low micromolar range (Fig. 7A, see SI Appendix for full details). Next, representative compounds that showed hNE inhibition with IC50 of less than 10 µM were further analyzed by high-resolution electrospray ionization (ESI) mass spectrometry (refer to SI Appendix for full details). Fig. 7B depicts the ESI mass spectrum of compound 4-16 (exact mass 321 Da) incubated with hNE (25,198 Da), and a peak shift from the original protein mass by 301 Da consistent with covalent addition of one molecule of 4-16 and loss of one fluorine atom and one hydrogen (likely from the protease’s catalytic serine). Likewise, other 1,2,3-triazole-substituted ESFs showed comparable peak shifts when incubated with hNE, consistent with covalent SuFEx modification of the protein.
Fig. 7.
(A) IC50 values of selected β-substituted ESFs against hNE; (B) ESI mass spectrum of the SuFEx-adduct of elastase and selected probe; (C) Molecular docking results: Residues defining the binding site are shown as gray sticks, and volumes represented as semitransparent surfaces. Ligand 4-16 is shown as yellow sticks; hydrogen bonds are shown as green dashed lines; incipient covalent bond is shown in purple.
Molecular docking simulations were performed to build a binding mode model of the most active compound (4-16), applying the reactive docking protocol (50) to model the ligand free and untethered with the intact warhead before the formation of the covalent adduct. In the predicted binding mode, the ligand 4-16 adopts an orientation similar to the SuFEx-derived hNE binders that we previously reported (Fig. 7C) (36). The hydrophobic pocket roughly defined by Ser214, Val216, and Val190 remains relevant to stabilizing the ligand, revealing significant engagement with the β-triazole moiety. This interaction suggests that the heterocycle could be stabilized by potential stacking with the peptide amides of Phe215 and Val216 backbones. The cis conformation orients the trifluorotoluene group of 4-16 such that it points toward the bulk solvent, reaching out to the side chains of Phe215 and Leu99. Finally, a potential hydrogen-bond interaction with the backbone amide of Gly193 appears to further stabilize one of the sulfone oxygens in a conformation highly favorable to facilitate the formation of the nascent covalent bond between sulfur and Ser195 Oγ.
We have demonstrated DOC as a powerful method for discovering functional molecules by expanding the available click-pathways of SASF hubs to include the Michael addition of amines, 1H-1,2,3-triazole, halides, and carboxylic acids. Using the DOC approach, we have synthesized a collection of unprecedented β-substituted ESFs in excellent yield, and as single stereoisomers. The relative SuFEx reactivity of β-substituted ESFs can be readily tuned through judicious choice of β-substituent, and hence has potential application as a tool for developing covalent inhibitors. This is showcased through the discovery of a selection of covalent inhibitors of hNE, most notably the 1,2,3-triazole and carboxylic acid adducts, demonstrating the importance of the differing “push- and pull-like” distribution of electron density on ligand SuFExability. We advocate DOC as a valuable tool for discovery chemistry that will find wide application in covalent enzyme inhibition, target identification, mapping of enzyme binding sites, and probing protein-protein interactions.
Materials and Methods
Synthesis of SASFs.
Method 1.
To a solution of the required terminal alkyne (1.00 mmol) in diethyl ether (5.00 mL) at −78 °C was added nBuLi (1.05 eq.) dropwise. The resulting mixture was stirred at −78 °C for 0.5 h before the addition of fluorosulfonic anhydride (1.50 mmol, 1.50 eq.). After stirring at −78 °C for 0.5 h, the reaction was warmed to room temperature and the solvent was then removed under reduced pressure. The crude mixture was then purified by flash column chromatography (5% EtOAc in hexanes) to obtain the analytically pure product.
Method 2.
To a solution of the required terminal alkyne (10.0 mmol) in anhydrous THF (10.0 mL) at −78 °C was added nBuLi (1.05 eq.) dropwise and stirred at −78 °C for 1 h. To the cooled reaction mixture was added a balloon of SO2 by cannula, first bubbled through conc. H2SO4 (20.0 mL) and stirred at −78 °C for 1 h. The reaction mixture was warmed to room temperature and the remaining SO2 removed by vacuum, purging with argon. The reaction mixture was then diluted with anhydrous THF (20.0 mL), cooled to −78 °C and N-fluorobenzenesulfonimide (6.30 g, 20.0 mmol) was added in one portion and removed from the cold bath, and stirred at room temperature for 3 h. The mixture was then filtered, and the solvent removed under reduced pressure. The crude was redissolved in the minimum amount of diethyl ether, triturated with petroleum ether (50.0 mL), filtered, and the filtrate solvent was removed under reduced pressure. The crude mixture was purified by flash column to obtain the desired compound.
General Procedure A for the Preparation of Compounds 2-1 to 2-22 (Fig. 2A) and 4-1 to 4-23 (Fig. 3A).
To a solution of the required SASF (100 μmol) in acetonitrile (2.00 mL) was added the required amine (100 μmol) and the reaction mixture was stirred at room temperature until full conversion was observed by Thin-layer chromatography (TLC). The reaction mixture was diluted with ethyl acetate, washed with brine and H2O, dried over sodium sulfate, filtered, and the solvent removed under reduced pressure to obtain the desired compound (45 examples, 53 to 99% isolated yield).
General Procedure B for the Preparation of Compounds 4-23 to 4-29 (Fig. 3C).
To a solution of 2-(triisopropylsilyl)ethyne-1-sulfonyl fluoride (200 μmol) in acetonitrile (2.00 mL) was added the required amine (300 μmol) and the reaction mixture was stirred at room temperature until full conversion was observed by TLC. The reaction mixture was diluted with ethyl acetate, washed with brine and H2O, dried over sodium sulfate, filtered, and the solvent removed under reduced pressure to obtain the desired compound (6 examples, 53 to 72% isolated yield).
General Procedure C for the Preparation of Compounds 6-1 to 6-8 (Fig. 4A).
To a solution of the required SASF (200 μmol) in acetonitrile (1.00 mL) was added triethylamine trihydrofluoride (100 μmol) and the reaction mixture was stirred at room temperature for 1 h. The reaction mixture was diluted with ethyl acetate, washed with brine and H2O, dried over sodium sulfate, filtered, and the solvent removed under reduced pressure to obtain the desired compound (8 examples, 82 to 99% isolated yield).
General Procedure D for the Preparation of Compounds 6-9 to 6-17 (Fig. 4A).
To a solution of the required SASF (100 μmol) in CH2Cl2 (500 μL) at 0 °C was added triethylamine hydrochloride (110 μmol) and the reaction mixture was stirred at room temperature for 16 h. The reaction mixture was diluted with ethyl acetate, washed with brine and H2O, dried over sodium sulfate, filtered, the solvent removed under reduced pressure and the crude product was purified by flash column chromatography to obtain the desired compound (9 examples, 64 to 91% isolated yield).
General Procedure E for the Preparation of Compound 6-18 (Fig. 4A).
To a solution of the required SASF (100 μmol) in acetonitrile (1.00 mL) was added lithium iodide (100 μmol) and AcOH (100 μmol) and the reaction mixture was stirred at room temperature until full conversion was observed by TLC. The reaction mixture was diluted with ethyl acetate, washed with brine and H2O, dried over sodium sulfate, filtered, and the solvent removed under reduced pressure to obtain the desired compound (1 example, 95% isolated yield).
General Procedure F for the Preparation of Compounds 7-1 to 7-17 (Fig. 5A).
To a solution of the required SASF (100 μmol) and carboxylic acid (100 μmol) in acetonitrile (500 μL) was added Et3N (110 μmol) and the reaction mixture was stirred at room temperature for 30 min. The reaction mixture was diluted with ethyl acetate, washed with brine and H2O, dried over sodium sulfate, filtered, and the solvent removed under reduced pressure to obtain the desired compound (17 examples, 79 to 98% isolated yield).
Protease Activity Assays [see Zheng et al. (36)].
hNE activity was measured in a total volume of 100 µL in a reaction buffer of PBS (pH 7.4) and 0.05% (vol/vol) Nonidet P 40 Substitute (Sigma). The final composition of each reaction was 5 nM hNE (Elastin Products Corp), 50 µM AAPV-aminomethylcoumarin (AMC) substrate (Millipore), ∼2.5% dimethyl sulfoxide (Fisher), and various concentrations of compounds as inhibitors. hNE was incubated with compounds for 10 min at room temperature before the addition of AAPV-AMC. Residual proteolytic activity was measured kinetically at 25 °C using an Envision microplate reader for a total of 30 min at 30-s intervals. Only data points “reflecting linear substrate conversion were used to determine relative protease activity. IC50 values were obtained by fitting the data to a dose-response inhibition, log (inhibitor) vs. response—variable slope (four parameters) using GraphPad Prism.
Mass Spectrometry Analysis [see Zheng et al. (36)].
hNE was resuspended in 50 mM sodium acetate (NaOAc, pH 4.5), 100 mM NaCl to 0.2 mg/mL final concentration. DMSO solution of each compound (10 mM) was diluted 1:10 in the above buffer, then added in a compound:hNE ratio = 3:1 and incubated at room temperature for 1 h prior to analysis by MALDI-TOF mass spectrometry.
Molecular Modeling.
The crystal structure of hNE was retrieved from the Protein Data Bank: (PDB id: 6e69). Hydrogens were added with Reduce, then the structure was prepared following the standard AutoDock protocol. A cubic docking grid box of 60 × 60 × 60 points (22.5 Å side) was defined around Ser195. Dockings were performed with AutoDock v.4.2.6 generating 100 poses using the default LGA parameters. The top energy pose was selected and analyzed. Figures were generated using Python Molecular Viewer.
Supplementary Material
Acknowledgments
The current work was financially supported by the National Institutes of Health R01GM117145 (K.B.S.), R35GM136286 (D.W.W.), R01GM069832 (S.F.), K99GM138758 (S.K.), T32AI7354-27 (J.L.W.), and the NCI Cancer Center Support Grant 5P30CA045508 (J.E.M.). We thank The F. M. Kirby Foundation, Sunshine Foundation, S. J. Edwards, The Starr Foundation, The Wasily Family Foundation, and La Trobe University for generous support (J.E.M.). We thank the ARC for funding (J.E.M.) (Future Fellowship; FT170100156). We thank Jie Sun and the State Key Laboratory of Organometallic Chemistry, Shanghai Institute of Organic Chemistry, CAS, for performing X-ray crystallography of compounds 2-1 and 7-11, and the X-ray Crystallography Facility, UC San Diego, for compound 4-17. We thank Dr. Suhua Li, Sun Yat-Sen University, for enlightening discussions.
Footnotes
Reviewers: N.D.B., Pomona College Department of Chemistry; J.N., Boston College; and C.B., RWTH Aachen University.
The authors declare no competing interest.
1Where yields were lower than expected, the mass balance could be accounted for in unreacted starting materials, especially when bulky amine substrates or SASFs with electron donating groups on the aromatic ring were utilized.
This article contains supporting information online at https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.2208540119/-/DCSupplemental.
Data, Materials, and Software Availability
All study data are included in the article and/or supporting information.
References
- 1.Smedley C. J., et al. , Diversity oriented clicking (DOC): Divergent synthesis of SuFExable pharmacophores from 2-substituted-alkynyl-1-sulfonyl fluoride (SASF) hubs. Angew. Chem. Int. Ed. Engl. 59, 12460–12469 (2020). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Kolb H. C., Finn M. G., Sharpless K. B., Click chemistry: Diverse chemical function from a few good reactions. Angew. Chem. Int. Ed. Engl. 40, 2004–2021 (2001). [DOI] [PubMed] [Google Scholar]
- 3.Barrow A. S., et al. , The growing applications of SuFEx click chemistry. Chem. Soc. Rev. 48, 4731–4758 (2019). [DOI] [PubMed] [Google Scholar]
- 4.Giel M.-C., Smedley C. J., Moses J. E., “Science of synthesis: Click chemistry” in Science of Synthesis: Click Chemistry, Rutjes F. P. J. T., Ed. (Thieme, Stuttgart, 2021), vol. 1, pp. 435–484. [Google Scholar]
- 5.Smedley C. J., et al. , Accelerated SuFEx click chemistry for modular synthesis. Angew. Chem. Int. Ed. Engl. 61, e202112375 (2022). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Abdul Fattah T., Saeed A., Albericio F., Recent advances towards sulfur (VI) fluoride exchange (SuFEx) click chemistry. J. Fluor. Chem. 213, 87–112 (2018). [Google Scholar]
- 7.Lee C., et al. , The emerging applications of sulfur(VI) fluorides in catalysis. ACS Catal. 11, 6578–6589 (2021). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Dong J., Krasnova L., Finn M. G., Sharpless K. B., Sulfur(VI) fluoride exchange (SuFEx): Another good reaction for click chemistry. Angew. Chem. Int. Ed. Engl. 53, 9430–9448 (2014). [DOI] [PubMed] [Google Scholar]
- 9.Li S., Wu P., Moses J. E., Sharpless K. B., Multidimensional SuFEx click chemistry: Sequential sulfur(VI) fluoride exchange connections of diverse modules launched from an SOF4 hub. Angew. Chem. Int. Ed. Engl. 56, 2903–2908 (2017). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Zheng Q., Dong J., Sharpless K. B., Ethenesulfonyl fluoride (ESF): An on-water procedure for the kilogram-scale preparation. J. Org. Chem. 81, 11360–11362 (2016). [DOI] [PubMed] [Google Scholar]
- 11.Giel M.-C., et al. , Metal-free synthesis of functional 1-substituted-1,2,3-triazoles from ethenesulfonyl fluoride and organic azides. Angew. Chem. Int. Ed. Engl. 59, 1181–1186 (2020). [DOI] [PubMed] [Google Scholar]
- 12.Smedley C. J., et al. , 1-Bromoethene-1-sulfonyl fluoride (BESF) is another good connective hub for SuFEx click chemistry. Chem. Commun. (Camb.) 54, 6020–6023 (2018). [DOI] [PubMed] [Google Scholar]
- 13.Leng J., Qin H.-L., 1-Bromoethene-1-sulfonyl fluoride (1-Br-ESF), a new SuFEx clickable reagent, and its application for regioselective construction of 5-sulfonylfluoro isoxazoles. Chem. Commun. (Camb.) 54, 4477–4480 (2018). [DOI] [PubMed] [Google Scholar]
- 14.Thomas J., Fokin V. V., Regioselective synthesis of fluorosulfonyl 1,2,3-triazoles from bromovinylsulfonyl fluoride. Org. Lett. 20, 3749–3752 (2018). [DOI] [PubMed] [Google Scholar]
- 15.Ball N. D., “Properties and Applications of Sulfur (VI) Fluorides” in Emerging Fluorinated Motifs: Synthesis, Properties, and Applications 2, Ma J.-A., Cahard D., Eds. (WileyVCH, Weinheim, 2020), pp. 621–674. [Google Scholar]
- 16.Lou T. S.-B., Willis M. C., Sulfonyl fluorides as targets and substrates in the development of new synthetic methods. Nat. Rev. Chem. 6, 146–162 (2022). [DOI] [PubMed] [Google Scholar]
- 17.Mukherjee P., et al. , Sulfonamide synthesis via calcium triflimide activation of sulfonyl fluorides. Org. Lett. 20, 3943–3947 (2018). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Mahapatra S., et al. , SuFEx activation with Ca(NTf2)2: A unified strategy to access sulfamides, sulfamates, and sulfonamides from S(VI) fluorides. Org. Lett. 22, 4389–4394 (2020). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Liang D.-D., et al. , Silicon-free SuFEx reactions of sulfonimidoyl fluorides: Scope, enantioselectivity, and mechanism. Angew. Chem. Int. Ed. Engl. 59, 7494–7500 (2020). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Zhang Z.-X., Willis M. C., Sulfondiimidamides as new functional groups for synthetic and medicinal chemistry. Chem 8, 1137–1146 (2022). [Google Scholar]
- 21.Khumalo M. F., et al. , Synthesis of novel 1,2,4-thiadiazinane 1,1-dioxides via three component SuFEx type reaction. RSC Advances 8, 37503–37507 (2018). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Xiang J., Jiang W., Gong J., Fuchs P. L., Stereospecific alkenylation of C−H bonds via reaction with β-heteroatom-functionalized trisubstituted vinyl triflones. J. Am. Chem. Soc. 119, 4123–4129 (1997). [Google Scholar]
- 23.Jones L. H., Emerging utility of fluorosulfate chemical probes. ACS Med. Chem. Lett. 9, 584–586 (2018). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Liu F., et al. , Biocompatible SuFEx click chemistry: Thionyl tetrafluoride (SOF4 )-derived connective hubs for bioconjugation to DNA and proteins. Angew. Chem. Int. Ed. Engl. 58, 8029–8033 (2019). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Choi E. J., Jung D., Kim J.-S., Lee Y., Kim B. M., Chemoselective tyrosine bioconjugation through sulfate click reaction. Chemistry 24, 10948–10952 (2018). [DOI] [PubMed] [Google Scholar]
- 26.Kitamura S., et al. , Sulfur(VI) fluoride exchange (SuFEx)-enabled high-throughput medicinal chemistry. J. Am. Chem. Soc. 142, 10899–10904 (2020). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Chen W., et al. , Arylfluorosulfates inactivate intracellular lipid binding protein(s) through chemoselective SuFEx reaction with a binding Site Tyr Residue. J. Am. Chem. Soc. 138, 7353–7364 (2016). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Narayanan A., Jones L. H., Sulfonyl fluorides as privileged warheads in chemical biology. Chem. Sci. (Camb.) 6, 2650–2659 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Mortenson D. E., et al. , “Inverse Drug Discovery” strategy to identify proteins that are targeted by latent electrophiles as exemplified by aryl fluorosulfates. J. Am. Chem. Soc. 140, 200–210 (2018). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Grimster N. P., et al. , Aromatic sulfonyl fluorides covalently kinetically stabilize transthyretin to prevent amyloidogenesis while affording a fluorescent conjugate. J. Am. Chem. Soc. 135, 5656–5668 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Hett E. C., et al. , Rational targeting of active-site tyrosine residues using sulfonyl fluoride probes. ACS Chem. Biol. 10, 1094–1098 (2015). [DOI] [PubMed] [Google Scholar]
- 32.Warshel A., Bora R. P., Perspective: Defining and quantifying the role of dynamics in enzyme catalysis. J. Chem. Phys. 144, 180901 (2016). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Suydam I. T., Snow C. D., Pande V. S., Boxer S. G., Electric fields at the active site of an enzyme: Direct comparison of experiment with theory. Science 313, 200–204 (2006). [DOI] [PubMed] [Google Scholar]
- 34.Fried S. D., Boxer S. G., Electric fields and enzyme catalysis. Annu. Rev. Biochem. 86, 387–415 (2017). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Fried S. D., Bagchi S., Boxer S. G., Extreme electric fields power catalysis in the active site of ketosteroid isomerase. Science 346, 1510–1514 (2014). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Zheng Q., et al. , SuFEx-enabled, agnostic discovery of covalent inhibitors of human neutrophil elastase. Proc. Natl. Acad. Sci. U.S.A. 116, 18808–18814 (2019). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Gehrig S., et al. , Lack of neutrophil elastase reduces inflammation, mucus hypersecretion, and emphysema, but not mucus obstruction, in mice with cystic fibrosis-like lung disease. Am. J. Respir. Crit. Care Med. 189, 1082–1092 (2014). [DOI] [PubMed] [Google Scholar]
- 38.Nakamura H., Yoshimura K., McElvaney N. G., Crystal R. G., Neutrophil elastase in respiratory epithelial lining fluid of individuals with cystic fibrosis induces interleukin-8 gene expression in a human bronchial epithelial cell line. J. Clin. Invest. 89, 1478–1484 (1992). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Sagel S. D., Wagner B. D., Anthony M. M., Emmett P., Zemanick E. T., Sputum biomarkers of inflammation and lung function decline in children with cystic fibrosis. Am. J. Respir. Crit. Care Med. 186, 857–865 (2012). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Twigg M. S., et al. , The role of serine proteases and antiproteases in the cystic fibrosis lung. Mediators Inflamm. 2015, 293053 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Wagner C. J., Schultz C., Mall M. A., Neutrophil elastase and matrix metalloproteinase 12 in cystic fibrosis lung disease. Mol. Cell Pediatr. 3, 25 (2016). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Pandey K. C., De S., Mishra P. K., Role of proteases in chronic obstructive pulmonary disease. Front. Pharmacol. 8, 512 (2017). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Qiu Y., et al. , Biopsy neutrophilia, neutrophil chemokine and receptor gene expression in severe exacerbations of chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 168, 968–975 (2003). [DOI] [PubMed] [Google Scholar]
- 44.Motta J.-P., et al. , Food-grade bacteria expressing elafin protect against inflammation and restore colon homeostasis. Sci. Transl. Med. 4, 158ra144 (2012). [DOI] [PubMed] [Google Scholar]
- 45.Zheng Q., et al. , “Sleeping Beauty” phenomenon: SuFEx-enabled discovery of selective covalent inhibitors of human neutrophil elastase (2019) 10.26434/chemrxiv.7842020.v1 (February 28, 2022). [DOI] [PMC free article] [PubMed]
- 46.Hyatt J. A., Krutak J. J., Synthesis and chemistry of some 2-aminoethenesulfonyl fluorides. An unusual manganese dioxide oxidation. J. Org. Chem. 42, 169–170 (1977). [Google Scholar]
- 47.Leng J., Tang W., Fang W.-Y., Zhao C., Qin H.-L., A simple protocol for the stereoselective construction of enaminyl sulfonyl fluorides. Org. Lett. 22, 4316–4321 (2020). [DOI] [PubMed] [Google Scholar]
- 48.Wang Y., et al. , N-heterocyclic carbene-catalysed Peterson olefination reaction. Tetrahedron 72, 472–478 (2016). [Google Scholar]
- 49.Nie X., et al. , Introducing a new class of sulfonyl fluoride hubs via radical chloro-fluorosulfonylation of alkynes. Angew. Chem. Int. Ed. 60, 22035–22042 (2021). [DOI] [PubMed] [Google Scholar]
- 50.Backus K. M., et al. , Proteome-wide covalent ligand discovery in native biological systems. Nature 534, 570–574 (2016). [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
All study data are included in the article and/or supporting information.







